Repository logo
 

Identifying opportunities for timely diagnosis of bladder and renal cancer via abnormal blood tests: a longitudinal linked data study

Published version
Peer-reviewed

Change log

Authors

Walter, FM 
Mounce, L 
Abel, GA 
Singh, H 

Abstract

Background: Understanding pre-diagnostic test use could reveal diagnostic windows where more timely evaluation for cancer may be indicated.

Aim: To examine pre-diagnostic patterns of results of abnormal blood tests in bladder and renal cancer patients.

Design and setting: Retrospective cohort study using primary care and cancer registry data on bladder and renal cancer patients diagnosed between 2012-2015 in England.

Method: We examined the rates of patients with a first abnormal result in the year before diagnosis, for “generic” (full blood count components, inflammatory markers, calcium) and “organ-specific” blood tests (creatinine, liver function test components) which may lead to subsequent detection of incidental cancers. We used Poisson regression, to detect the month during which the cohort’s rate of each abnormal test started to increase from baseline, and examined the proportion of patients with a test found in the first half of the window, as these ‘early’ tests might represent opportunities where further evaluation could be initiated.

Results: Data from 4,533 bladder and renal cancer patients were analysed. The monthly rate of patients with a first abnormal test increased towards the time of cancer diagnosis. Abnormalities of both generic and organ-specific tests started to increase from 6-8 months pre-diagnosis, with 25-40% of these patients having an abnormal test in the “early half” of the diagnostic window.

Conclusion: Population-level signals of bladder and renal cancer can be observed in abnormalities in commonly performed primary care blood tests up to 8 months before diagnosis, indicating the potential for earlier diagnosis in some patients.

Description

Keywords

bladder cancer, diagnostic tests, routine, early detection of cancer, primary health care, renal cancer, test utilisation

Journal Title

British Journal of General Practice

Conference Name

Journal ISSN

0960-1643
1478-5242

Volume Title

Publisher

Royal College of General Practitioners
Sponsorship
Wellcome Trust (via University of Keele) (R5243 C210)
Cancer Research UK (C96/A25177)
National Institute for Health and Care Research (IS-BRC-1215-20014)
HS is supported by by the Houston Veterans Administration (VA) Health Services Research and Development (HSR&D) Center for Innovations in Quality, Effectiveness, and Safety (CIN13-413), the VA HSR&D Service (CRE17-127 and the Presidential Early Career Award for Scientists and Engineers USA 14-274), the Agency for Healthcare Research and Quality (R01HS27363), and the Gordon and Betty Moore Foundation. GDS is supported by The Mark Foundation for Cancer Research, the Cancer Research UK Cambridge Centre [C9685/A25177], the Renal Cancer Research Fund, Kidney Cancer UK, and NIHR Cambridge Biomedical Research Centre (BRC-1215-20014).